Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA: 600521)
China flag China · Delayed Price · Currency is CNY
16.40
-0.37 (-2.21%)
Sep 6, 2024, 3:00 PM CST

Zhejiang Huahai Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
1,010830.471,168487.54929.82569.6
Upgrade
Depreciation & Amortization
816.27767.61672.01563.07470.83410.66
Upgrade
Other Amortization
29.622.017.082.452.31.77
Upgrade
Loss (Gain) From Sale of Assets
0.650.29-3.59-0.6-19.15-0.02
Upgrade
Asset Writedown & Restructuring Costs
43.7439.4121.6910.3513.5816.83
Upgrade
Loss (Gain) From Sale of Investments
150.37161.9766.48-442.95-26.0917.84
Upgrade
Provision & Write-off of Bad Debts
3.53-7.9345.3714.7329.6-10.47
Upgrade
Other Operating Activities
308.65241.6986.91220.3378.16304.6
Upgrade
Change in Accounts Receivable
-114.11269.5-818.89-388.87-582.45497.18
Upgrade
Change in Inventory
106.08-140.05-679.92-386.81-184.07-108.81
Upgrade
Change in Accounts Payable
263.8419.99669.89679.92589.2218.79
Upgrade
Change in Other Net Operating Assets
-25.01-0.4981.61113.745.913.52
Upgrade
Operating Cash Flow
2,6242,2171,243938.431,5551,754
Upgrade
Operating Cash Flow Growth
59.76%78.40%32.42%-39.67%-11.32%2483.29%
Upgrade
Capital Expenditures
-1,451-1,592-2,316-2,434-1,276-794.31
Upgrade
Sale of Property, Plant & Equipment
5.294.8410.729.9432.194.15
Upgrade
Investment in Securities
-40.63-18.7-106.6658.19-113.69-6.97
Upgrade
Other Investing Activities
-14.45-16.53-20.359.480.446.07
Upgrade
Investing Cash Flow
-1,501-1,623-2,433-2,357-1,358-791.06
Upgrade
Long-Term Debt Issued
-3,3213,8733,2386,1344,268
Upgrade
Total Debt Issued
4,0673,3213,8733,2386,1344,268
Upgrade
Long-Term Debt Repaid
--3,321-2,732-1,931-5,135-4,519
Upgrade
Total Debt Repaid
-4,910-3,321-2,732-1,931-5,135-4,519
Upgrade
Net Debt Issued (Repaid)
-843.15-0.61,1401,307998.68-250.82
Upgrade
Issuance of Common Stock
--37.68371.82-970
Upgrade
Repurchase of Common Stock
-251.51-71-172.43-150.01--
Upgrade
Common Dividends Paid
-328.56-556.01-318.32-387.21-392.83-208.88
Upgrade
Other Financing Activities
-14.52-16.63-78.36-23.31-9.49-910.63
Upgrade
Financing Cash Flow
-1,438-644.23609.041,118596.35-400.33
Upgrade
Foreign Exchange Rate Adjustments
-39.942954.65-43.49-85.3428.69
Upgrade
Net Cash Flow
-353.98-20.98-526.18-343.57708.93591.25
Upgrade
Free Cash Flow
1,173624.63-1,074-1,496278.97959.64
Upgrade
Free Cash Flow Growth
-----70.93%-
Upgrade
Free Cash Flow Margin
12.84%7.52%-12.99%-22.52%4.30%17.81%
Upgrade
Free Cash Flow Per Share
0.810.43-0.74-1.040.190.69
Upgrade
Cash Interest Paid
0.120.060.060.06--
Upgrade
Cash Income Tax Paid
580.26614.3206.43227.84117.59183.22
Upgrade
Levered Free Cash Flow
742.1914.03-1,715-1,721-39.98-344.8
Upgrade
Unlevered Free Cash Flow
880.37158.83-1,578-1,61744.6-204.39
Upgrade
Change in Net Working Capital
-518.76-112.79986.12109.4617.32343.7
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.